Alastair L. Wilkins

Bristol, ENG BS105NB, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal: Journal of neurology

Published: September 23, 2020

Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington's chorea.

Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington's chorea.

Journal: Brain pathology (Zurich, Switzerland)

Published: June 25, 2020

Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.

Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: June 16, 2020

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia.

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia.

Journal: Nature communications

Published: November 22, 2019

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.

Journal: JAMA

Published: January 16, 2019

shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.

shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.

Journal: The Journal of pathology

Published: June 26, 2018

Advising patients seeking stem cell interventions for multiple sclerosis.

Advising patients seeking stem cell interventions for multiple sclerosis.

Journal: Practical neurology

Published: May 07, 2018

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis.

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis.

Journal: Stem cells translational medicine

Published: March 03, 2018

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells.

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells.

Journal: Acta neuropathologica

Published: January 10, 2018

Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays.

Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays.

Journal: Journal of clinical pathology

Published: December 16, 2017

Treatment of Cerebellar Ataxia in the Context of Systemic Diseases.

Treatment of Cerebellar Ataxia in the Context of Systemic Diseases.

Journal: Current treatment options in neurology

Published: November 28, 2017

Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.

Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: October 25, 2017

Showing 1-12 of 51

Last Updated: 09/26/2026